BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18467665)

  • 21. Isolation and characterization of kidney-derived stem cells.
    Gupta S; Verfaillie C; Chmielewski D; Kren S; Eidman K; Connaire J; Heremans Y; Lund T; Blackstad M; Jiang Y; Luttun A; Rosenberg ME
    J Am Soc Nephrol; 2006 Nov; 17(11):3028-40. PubMed ID: 16988061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic mechanisms in the biology of prostate cancer.
    Schulz WA; Hoffmann MJ
    Semin Cancer Biol; 2009 Jun; 19(3):172-80. PubMed ID: 19429481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the β-catenin gene.
    Akpa MM; Iglesias DM; Chu LL; Cybulsky M; Bravi C; Goodyer PR
    J Biol Chem; 2015 Jan; 290(4):2279-88. PubMed ID: 25331950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney stem cells in development, regeneration and cancer.
    Dziedzic K; Pleniceanu O; Dekel B
    Semin Cell Dev Biol; 2014 Dec; 36():57-65. PubMed ID: 25128731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.
    Murphy AJ; Pierce J; de Caestecker C; Taylor C; Anderson JR; Perantoni AO; de Caestecker MP; Lovvorn HN
    J Pediatr Surg; 2012 Jun; 47(6):1239-49. PubMed ID: 22703800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
    Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
    Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for cancer stem cells in human endometrial carcinoma.
    Hubbard SA; Friel AM; Kumar B; Zhang L; Rueda BR; Gargett CE
    Cancer Res; 2009 Nov; 69(21):8241-8. PubMed ID: 19843861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary and multipassage culture of human fetal kidney epithelial progenitor cells.
    Loo D; Beltejar C; Hooley J; Xu X
    Methods Cell Biol; 2008; 86():241-55. PubMed ID: 18442650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for intermediate mesoderm and kidney progenitor cell specification by Pax2 and PTIP dependent mechanisms.
    Ranghini EJ; Dressler GR
    Dev Biol; 2015 Mar; 399(2):296-305. PubMed ID: 25617721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 Enables metabolic fitness and self-renewal of nephron progenitor cells.
    Li Y; Liu J; Li W; Brown A; Baddoo M; Li M; Carroll T; Oxburgh L; Feng Y; Saifudeen Z
    Development; 2015 Apr; 142(7):1228-41. PubMed ID: 25804735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Characterization of the Wilms Tumor Cancer Stem Cell.
    Petrosyan A; Villani V; Aguiari P; Thornton ME; Wang Y; Rajewski A; Zhou S; Cravedi P; Grubbs BH; De Filippo RE; Sedrakyan S; Lemley KV; Csete M; Da Sacco S; Perin L
    Adv Sci (Weinh); 2023 Jul; 10(20):e2206787. PubMed ID: 37114795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of stem cell differentiation.
    Wu H; Sun YE
    Pediatr Res; 2006 Apr; 59(4 Pt 2):21R-5R. PubMed ID: 16549544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic regulator polycomb group protein complexes control cell fate and cancer.
    Kanno R; Janakiraman H; Kanno M
    Cancer Sci; 2008 Jun; 99(6):1077-84. PubMed ID: 18422744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sall1 balances self-renewal and differentiation of renal progenitor cells.
    Basta JM; Robbins L; Kiefer SM; Dorsett D; Rauchman M
    Development; 2014 Mar; 141(5):1047-58. PubMed ID: 24550112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting Stages of Human Kidney Development and Tumorigenesis with Surface Markers Affords Simple Prospective Purification of Nephron Stem Cells.
    Pode-Shakked N; Pleniceanu O; Gershon R; Shukrun R; Kanter I; Bucris E; Pode-Shakked B; Tam G; Tam H; Caspi R; Pri-Chen S; Vax E; Katz G; Omer D; Harari-Steinberg O; Kalisky T; Dekel B
    Sci Rep; 2016 Mar; 6():23562. PubMed ID: 27020553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycomb complexes and epigenetic states.
    Schwartz YB; Pirrotta V
    Curr Opin Cell Biol; 2008 Jun; 20(3):266-73. PubMed ID: 18439810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.
    Dallosso AR; Hancock AL; Szemes M; Moorwood K; Chilukamarri L; Tsai HH; Sarkar A; Barasch J; Vuononvirta R; Jones C; Pritchard-Jones K; Royer-Pokora B; Lee SB; Owen C; Malik S; Feng Y; Frank M; Ward A; Brown KW; Malik K
    PLoS Genet; 2009 Nov; 5(11):e1000745. PubMed ID: 19956686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.
    Song D; Yue L; Wu G; Ma S; Guo L; Yang H; Liu Q; Zhang D; Xia Z; Wang L; Zhang J; Zhao W; Guo F; Wang J
    Tumour Biol; 2015 Sep; 36(10):7591-8. PubMed ID: 25921281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.